Lantern Pharma (LTRN) Short Interest Ratio & Short Volume $3.76 -0.23 (-5.76%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$3.83 +0.07 (+1.76%) As of 04:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lantern Pharma Short Interest DataLantern Pharma (LTRN) has a short interest of 262,100 shares, representing 3.21% of the float (the number of shares available for trading by the public). This marks a -5.10% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.2, indicating that it would take 2.2 days of the average trading volume of 81,606 shares to cover all short positions.Current Short Interest262,100 sharesPrevious Short Interest276,200 sharesChange Vs. Previous Month-5.10%Dollar Volume Sold Short$828.24 thousandShort Interest Ratio2.2 Days to CoverLast Record DateJune 30, 2025Outstanding Shares10,780,000 sharesFloat Size8,160,000 sharesShort Percent of Float3.21%Today's Trading Volume370,221 sharesAverage Trading Volume81,606 sharesToday's Volume Vs. Average454% Short Selling Lantern Pharma? Sign up to receive the latest short interest report for Lantern Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLTRN Short Interest Over TimeLTRN Days to Cover Over TimeLTRN Percentage of Float Shorted Over Time Lantern Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/2025262,100 shares $828.24 thousand -5.1%3.2%2.2 $3.16 6/15/2025276,200 shares $842.41 thousand +3.8%3.4%5.3 $3.05 5/31/2025266,200 shares $801.26 thousand +4.5%3.3%5.8 $3.01 5/15/2025254,800 shares $983.53 thousand +0.2%3.2%5.7 $3.86 4/30/2025254,200 shares $894.78 thousand -6.9%3.2%5.7 $3.52 4/15/2025273,100 shares $961.31 thousand +5.3%3.4%3.5 $3.52 3/31/2025259,400 shares $918.28 thousand +8.4%3.2%3.2 $3.54 3/15/2025239,400 shares $909.72 thousand +3.0%3.0%2.7 $3.80 2/28/2025232,400 shares $917.98 thousand +4.6%2.9%2.3 $3.95 2/15/2025222,200 shares $1.11 million -6.9%2.8%2.2 $5.01 Get the Latest News and Ratings for LTRN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lantern Pharma and its competitors with MarketBeat's FREE daily newsletter. 1/31/2025238,700 shares $1.18 million +27.4%3.0%2.4 $4.95 1/15/2025187,400 shares $661.52 thousand -3.6%2.3%2 $3.53 12/31/2024194,400 shares $620.14 thousand -4.6%2.4%3.1 $3.19 12/15/2024203,700 shares $701.75 thousand +27.2%2.5%3.8 $3.45 11/30/2024160,100 shares $513.92 thousand -0.5%2.0%3 $3.21 11/15/2024160,900 shares $569.59 thousand -2.8%2.0%3.5 $3.54 10/31/2024165,600 shares $517.50 thousand -6.4%2.1%3.9 $3.13 10/15/2024176,900 shares $626.23 thousand -6.9%2.2%3.8 $3.54 9/30/2024190,000 shares $697.30 thousand +6.1%2.4%3.8 $3.67 9/15/2024179,100 shares $719.98 thousand -19.8%2.2%3.3 $4.02 8/31/2024223,300 shares $913.30 thousand -4.2%2.8%3.6 $4.09 8/15/2024233,000 shares $999.57 thousand +11.0%2.9%3.5 $4.29 7/31/2024210,000 shares $882 thousand -13.8%2.6%2.8 $4.20 7/15/2024243,500 shares $1.06 million -21.2%3.1%2.7 $4.35 6/30/2024308,900 shares $1.44 million -7.4%3.9%2.7 $4.67 6/15/2024333,500 shares $1.79 million -20.6%4.2%2 $5.37 5/31/2024419,800 shares $2.55 million -3.4%5.3%1.7 $6.07 5/15/2024434,400 shares $2.75 million -10.3%5.5%1.3 $6.33 4/30/2024484,300 shares $2.47 million -2.6%6.2%1.5 $5.10 4/15/2024497,300 shares $2.97 million +18.2%6.3%1.6 $5.97 3/31/2024420,900 shares $3.70 million +191.1%5.3%1.5 $8.80 3/15/2024144,600 shares $1.26 million +112.7%1.8%0.6 $8.70 2/29/202468,000 shares $327.08 thousand +14.1%0.9%0.5 $4.81 2/15/202459,600 shares $239.00 thousand -14.2%0.8%1.6 $4.01 1/31/202469,500 shares $293.29 thousand -4.3%0.9%1.6 $4.22 1/15/202472,600 shares $295.48 thousand +17.1%1.0%1.6 $4.07 12/31/202362,000 shares $265.36 thousand -65.7%0.8%1.4 $4.28 12/15/2023180,500 shares $776.15 thousand -20.1%2.4%4.3 $4.30 11/30/2023226,000 shares $892.70 thousand +25.0%3.0%5.9 $3.95 11/15/2023180,800 shares $725.01 thousand +19.7%2.4%5.1 $4.01Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow 10/31/2023151,000 shares $374.48 thousand -2.6%2.0%5.8 $2.48 10/15/2023155,000 shares $509.95 thousand +0.1%2.1%5.9 $3.29 9/30/2023154,800 shares $527.87 thousand -0.3%2.1%4.9 $3.41 9/15/2023155,200 shares $630.11 thousand -3.5%2.1%4.1 $4.06 8/31/2023160,800 shares $726.82 thousand +2.9%2.2%3.8 $4.52 8/15/2023156,200 shares $729.45 thousand +9.4%2.1%3.6 $4.67 7/31/2023142,800 shares $661.16 thousand -2.9%1.9%3.3 $4.63 7/15/2023147,100 shares $728.15 thousand +5.2%2.0%3.6 $4.95 6/30/2023139,900 shares $789.04 thousand +0.1%1.9%3.9 $5.64 6/15/2023139,800 shares $826.22 thousand -0.1%1.9%4.6 $5.91 5/31/2023139,900 shares $728.88 thousand -0.9%1.9%4.8 $5.21 5/15/2023141,200 shares $748.36 thousand +0.7%1.9%5.2 $5.30 4/30/2023140,200 shares $686.98 thousand -2.4%2.1%5.6 $4.90 4/15/2023143,600 shares $722.31 thousand -0.4%2.1%5.1 $5.03 3/31/2023144,200 shares $696.49 thousand +0.9%2.1%4.7 $4.83 3/15/2023142,900 shares $661.63 thousand +0.4%2.1%3.7 $4.63 2/28/2023142,400 shares $781.76 thousand -0.8%2.1%3.9 $5.49 2/15/2023143,500 shares $777.77 thousand -14.3%2.0%4.1 $5.42 1/31/2023167,400 shares $1.01 million -2.0%2.3%2.9 $6.02 1/15/2023170,800 shares $935.98 thousand +15.7%2.3%3 $5.48 12/30/2022147,600 shares $891.50 thousand -1.0%2.0%2.6 $6.04 12/15/2022149,100 shares $814.09 thousand +2.8%2.0%2.9 $5.46 11/30/2022145,000 shares $725 thousand -2.1%2.0%3 $5.00 11/15/2022148,100 shares $827.88 thousand -3.0%1.8%3.1 $5.59 10/31/2022152,700 shares $639.81 thousand -1.0%1.9%3.5 $4.19 10/15/2022154,300 shares $742.18 thousand +57.9%2.0%6.3 $4.81 9/30/202297,700 shares $467.01 thousand +53.6%1.2%2.5 $4.78 9/15/202263,600 shares $318.64 thousand -2.8%0.8%1.7 $5.01 8/31/202265,400 shares $338.12 thousand -26.9%0.8%1.8 $5.17 8/15/202289,500 shares $581.75 thousand -5.3%1.1%2.4 $6.50 7/31/202294,500 shares $484.79 thousand +59.6%1.2%2.5 $5.13 7/15/202259,200 shares $319.09 thousand -7.2%0.8%1.6 $5.39 6/30/202263,800 shares $364.30 thousand -18.0%0.9%2.9 $5.71 6/15/202277,800 shares $390.56 thousand -13.3%1.1%3.5 $5.02 5/31/202289,700 shares $519.36 thousand -40.4%1.2%4 $5.79 5/15/2022150,500 shares $880.43 thousand -6.2%2.1%5.9 $5.85 4/30/2022160,400 shares $955.98 thousand -12.1%2.2%6.2 $5.96 4/15/2022182,400 shares $1.25 million -3.0%2.5%5.2 $6.88 3/31/2022188,000 shares $1.34 million -9.7%2.5%4.1 $7.15 3/15/2022208,200 shares $1.27 million -7.0%2.8%3.2 $6.10 2/28/2022223,900 shares $1.38 million +0.2%2.9%2.9 $6.16 2/15/2022223,400 shares $1.52 million -4.0%2.9%2.7 $6.81 1/31/2022232,700 shares $1.55 million -5.7%3.0%2.6 $6.65 1/15/2022246,800 shares $1.79 million +13.4%3.2%2.7 $7.27 12/31/2021217,700 shares $1.74 million +15.0%2.8%2.6 $7.98 12/15/2021189,300 shares $1.48 million -17.7%2.4%2.3 $7.81 11/30/2021230,100 shares $1.94 million +20.5%3.0%3.4 $8.44 11/15/2021190,900 shares $1.84 million -15.6%2.5%2.5 $9.66 10/29/2021226,200 shares $2.31 million +8.1%2.9%2.8 $10.21 10/15/2021209,300 shares $2.10 million -10.6%2.7%2.6 $10.01Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow 9/30/2021234,000 shares $2.62 million -10.9%3.0%2.7 $11.18 9/15/2021262,700 shares $3.17 million -2.7%3.4%3.4 $12.08 8/31/2021270,100 shares $3.81 million +0.2%3.5%3.6 $14.09 8/13/2021269,700 shares $3.40 million -5.2%3.5%4.3 $12.60 7/30/2021284,600 shares $3.67 million -14.2%3.7%4.9 $12.90 7/15/2021331,800 shares $4.43 million -0.8%4.3%5.4 $13.35 6/30/2021334,500 shares $4.88 million -15.8%4.3%5.1 $14.60 6/15/2021397,100 shares $5.98 million +0.5%5.1%5.1 $15.07 5/28/2021395,000 shares $5.97 million +27.0%5.1%3.9 $15.12 5/14/2021311,100 shares $4.29 million +0.6%4.0%2.6 $13.80 4/30/2021309,400 shares $4.89 million +33.7%4.0%2.3 $15.81 4/15/2021231,500 shares $3.72 million +1.5%3.0%1.4 $16.08 3/31/2021228,000 shares $4.11 million +40.0%3.0%1 $18.02 3/15/2021162,900 shares $3.09 million +45.3%2.2%0.8 $18.97 2/26/2021112,100 shares $1.89 million -6.6%1.6%0.6 $16.87 2/12/2021120,000 shares $2.23 million +41.3%1.7%0.7 $18.61 1/29/202184,900 shares $1.26 million -50.2%1.3%0.6 $14.86 1/15/2021170,400 shares $2.47 million No Change4.4%1.4 $14.51 LTRN Short Interest - Frequently Asked Questions What is Lantern Pharma's current short interest? Short interest is the volume of Lantern Pharma shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 262,100 shares of LTRN short. 3.21% of Lantern Pharma's shares are currently sold short. Learn More on Lantern Pharma's current short interest. What is a good short interest ratio for Lantern Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LTRN shares currently have a short interest ratio of 2.0. Learn More on Lantern Pharma's short interest ratio. What is a good short interest percentage for Lantern Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.21% of Lantern Pharma's floating shares are currently sold short. Is Lantern Pharma's short interest increasing or decreasing? Lantern Pharma saw a drop in short interest in the month of June. As of June 30th, there was short interest totaling 262,100 shares, a drop of 5.1% from the previous total of 276,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lantern Pharma's float size? Lantern Pharma currently has issued a total of 10,780,000 shares. Some of Lantern Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lantern Pharma currently has a public float of 8,160,000 shares. How does Lantern Pharma's short interest compare to its competitors? 3.21% of Lantern Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Lantern Pharma: Galectin Therapeutics Inc. (17.94%), Greenwich LifeSciences, Inc. (17.20%), Rapt Therapeutics (3.09%), Neumora Therapeutics, Inc. (16.13%), FitLife Brands Inc. (1.23%), Fate Therapeutics, Inc. (8.81%), Caribou Biosciences, Inc. (7.64%), Cardiol Therapeutics Inc. (2.36%), Korro Bio, Inc. (18.40%), Nkarta, Inc. (11.60%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Lantern Pharma stock? Short selling LTRN is an investing strategy that aims to generate trading profit from Lantern Pharma as its price is falling. LTRN shares are trading down $0.23 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lantern Pharma? A short squeeze for Lantern Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LTRN, which in turn drives the price of the stock up even further. How often is Lantern Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LTRN, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies GALT Short Squeeze GLSI Short Squeeze RAPT Short Squeeze NMRA Short Squeeze FTLF Short Squeeze FATE Short Squeeze CRBU Short Squeeze CRDL Short Squeeze KRRO Short Squeeze NKTX Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LTRN) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lantern Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lantern Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
